Sort
11,323 grants matching “glioblastoma”
Predictive biomarker development in lung cancer: ROS1 chromosomal rearrangements
$226,296Anthony John Iafrate · Massachusetts General Hospital · R21 · FY2011 · CA
Pharmacologic and Genomic Imaging Core
$226,120Mario Luca Suva · Brigham And Women'S Hospital · U19 · FY2024 · CA
Role of m6A RNA methylation in Regulation of Translation in Human Glioblastoma
$225,983Nikolaos Tapinos · Rhode Island Hospital · R21 · FY2019 · CA
Engineered Glioblastoma Tumor Immunity for Personalized Immunotherapy
$225,946Weiqiang Chen · New York University · R21 · FY2018 · EB
Flourine-18 labeled MDM2 antagonists for PET imaging
$225,803Satish K. Chitneni · Duke University · R21 · FY2021 · CA
Targeting invasive plasticity by inhibiting mitochondrial adaptations to matrix metalloproteinase loss
$225,803Laura Catherine Kelley · Duke University · R21 · FY2022 · CA
scFvPD1-FLT3 CAR T Cells for the Treatment of Relapsed Acute Myeloid Leukemia
$225,765Jianhua Yu · Beckman Research Institute/City Of Hope · R21 · FY2019 · CA
Predicting the probabilistic complex invasive map of GBM cells
$225,657Orit Lavi · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Predicting the adaptation processes of GBM cells due to spatiotemporal stimuli
$225,657Orit Lavi · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Investigating Cancer Stem Cells - Niche Interactions in Brain Tumor
$225,475Xing Fan · University Of Michigan At Ann Arbor · R01 · FY2015 · CA
Investigating Cancer Stem Cells - Niche Interactions in Brain Tumor
$225,475Xing Fan · University Of Michigan At Ann Arbor · R01 · FY2012 · CA
Investigating Cancer Stem Cells - Niche Interactions in Brain Tumor
$225,475Xing Fan · University Of Michigan At Ann Arbor · R01 · FY2016 · CA
Drug Sensitivity of Calcium Modulators from Brain Tumor
$225,438Jin-Ming Yang · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2006 · CA
Continuous Chromatography Device to Economically Purify Clinical-grade Antibodies
$225,369Anthony Charles Grabski · Semba Biosciences, Inc. · R43 · FY2012 · CA
Novel platform linking cancer-specific glycosylation with cell signaling outcomes
$225,250Karen L. Abbott · Univ Of Arkansas For Med Scis · R21 · FY2018 · CA
Targeting the anti-apoptotic protein survivin in glioma
$225,181Roswell Park Cancer Institute Corp · R21 · FY2005 · NS
Targeting the PI3K Pathway in Malignant Glioma
$225,167W K Alfred Yung · University Of Tx Md Anderson Can Ctr · P50 · FY2013 · CA
Project 4: Inhibiting Novel Autophagy Mediator ATG4B for Treating Glioblastoma
$225,118Shi-Yuan Cheng · Northwestern University At Chicago · P50 · FY2021 · CA
Tiptuximab Immunotherapeutic for Cancer
$225,000Dennis E Hallahan · Medical Guidance Systems, Llc · R41 · FY2014 · CA
Personalized Neural Stem Cell Therapy for Cancer
$225,000Susan Nichols · Falcon Therapeutics, Inc. · R41 · FY2017 · TR
Novel therapeutic approach in treatment of glioblastoma using sustained delivery of Connxin43 carboxy-terminal peptide encapsulated in biodegradable nanoparticles in combination with temozolomide
$225,000Christina Grek · Xequel Bio, Inc. · R43 · FY2015 · CA
Validation of a Novel Treatment for Glioblastoma
$225,000Gregory Stein · Curtana Pharmaceuticals, Inc. · R41 · FY2014 · CA
Fiber Scanning Stimulated Raman Scattering (SRS) Endoscope
$225,000Christian Freudiger · Invenio Imaging Inc. · R43 · FY2014 · CA
AutoRegister: A system for enhancing the accuracy of tumor change detection
$225,000Nicholas John Schmansky · Corticometrics, Llc · R41 · FY2014 · CA
New anti-glioblastoma metabolic compounds with high potential for Blood Brain Barrier penetration
$225,000Krzysztof Reiss · Waypath Pharma Llc · R41 · FY2022 · CA